NASDAQ:RWLK ReWalk Robotics (RWLK) Stock Forecast, Price & News $0.74 -0.02 (-2.63%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$0.73▼$0.7750-Day Range$0.60▼$0.8552-Week Range$0.56▼$1.01Volume205,563 shsAverage Volume172,000 shsMarket Capitalization$44.36 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media ReWalk Robotics MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside305.4% Upside$3.00 Price TargetShort InterestBearish1.48% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.63Based on 3 Articles This WeekInsider TradingAcquiring Shares$185,224 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.94 out of 5 starsMedical Sector594th out of 968 stocksSurgical Appliances & Supplies Industry11th out of 18 stocks 3.5 Analyst's Opinion Consensus RatingReWalk Robotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.00, ReWalk Robotics has a forecasted upside of 305.4% from its current price of $0.74.Amount of Analyst CoverageReWalk Robotics has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted1.48% of the outstanding shares of ReWalk Robotics have been sold short.Short Interest Ratio / Days to CoverReWalk Robotics has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in ReWalk Robotics has recently increased by 4.00%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldReWalk Robotics does not currently pay a dividend.Dividend GrowthReWalk Robotics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RWLK. Previous Next 2.0 News and Social Media Coverage News SentimentReWalk Robotics has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for ReWalk Robotics this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for RWLK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added ReWalk Robotics to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ReWalk Robotics insiders have bought 661.71% more of their company's stock than they have sold. Specifically, they have bought $185,224.00 in company stock and sold $24,317.00 in company stock.Percentage Held by InsidersOnly 2.10% of the stock of ReWalk Robotics is held by insiders.Percentage Held by InstitutionsOnly 3.58% of the stock of ReWalk Robotics is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for ReWalk Robotics are expected to remain at ($0.35) per share in the coming year.Price to Earnings Ratio vs. the MarketThe P/E ratio of ReWalk Robotics is -2.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ReWalk Robotics is -2.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioReWalk Robotics has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About ReWalk Robotics (NASDAQ:RWLK) StockReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.Read More RWLK Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RWLK Stock News HeadlinesSeptember 20, 2023 | finance.yahoo.comReWalk Robotics Offers Thanks to Former Director for His Loyal Service and Valuable ContributionsSeptember 19, 2023 | americanbankingnews.comReWalk Robotics (NASDAQ:RWLK) Now Covered by Analysts at StockNews.comSeptember 23, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.September 19, 2023 | americanbankingnews.comComparing OceanTech Acquisitions I (NASDAQ:OTEC) & ReWalk Robotics (NASDAQ:RWLK)September 6, 2023 | finance.yahoo.comShareholders May Not Be So Generous With ReWalk Robotics Ltd.'s (NASDAQ:RWLK) CEO Compensation And Here's WhySeptember 6, 2023 | finance.yahoo.comReWalk Robotics Ltd. to Present Virtually at H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 5, 2023 | finance.yahoo.comReWalk Robotics Announces Additional Change to Board of DirectorsSeptember 5, 2023 | finance.yahoo.comReWalk Robotics Announces Additional Change to Board of DirectorsSeptember 23, 2023 | Altimetry (Ad)Biden's latest bailout--terrible for America?And a consultant for the Dept. of Defense (Joel Litman) says this is all leading to an event in the next 20 months that could help some get vastly wealthier… but also make it harder than ever to hang onto any money you make.This might be the most important development affecting you and your money over the next few years—August 14, 2023 | markets.businessinsider.comH.C. Wainwright Remains a Buy on Rewalk Robotics (RWLK)August 12, 2023 | finanznachrichten.deReWalk Robotics Ltd.: ReWalk Robotics Announces Closing of Acquisition of AlterGAugust 11, 2023 | markets.businessinsider.comReWalk Robotics Reports Second Quarter 2023 Financial ResultsAugust 11, 2023 | finance.yahoo.comReWalk Robotics Announces Closing of Acquisition of AlterGAugust 10, 2023 | markets.businessinsider.comRewalk Robotics (RWLK) Gets a Buy from H.C. WainwrightAugust 9, 2023 | finance.yahoo.comHow ReWalk's $19M acquisition could help it turn a profit after 22 yearsAugust 9, 2023 | finanznachrichten.deReWalk Robotics Ltd.: ReWalk Robotics to Acquire AlterG; Acquisition Builds Commercial Scale and Accelerates Path to ProfitabilityAugust 8, 2023 | finance.yahoo.comReWalk Robotics to Acquire AlterG; Acquisition Builds Commercial Scale and Accelerates Path to ProfitabilityAugust 3, 2023 | finance.yahoo.comReWalk Robotics to Report Second Quarter Financial Results on August 11, 2023July 29, 2023 | finanznachrichten.deReWalk Robotics Ltd.: ReWalk Robotics Announces Planned Changes to Board of DirectorsJuly 28, 2023 | finance.yahoo.comReWalk Robotics Announces Planned Changes to Board of DirectorsJuly 11, 2023 | finance.yahoo.comReWalk Robotics Ltd. to Present at the Emerging Growth Conference on July 12July 5, 2023 | finance.yahoo.comReWalk Robotics Ltd. to Host Call to Discuss Medicare Proposal to Establish Personal Exoskeletons Within a Benefit Category for Eligible BeneficiariesJuly 3, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Technology Stocks: Tesla (TSLA), Rewalk Robotics (RWLK)June 30, 2023 | finance.yahoo.comReWalk Robotics Applauds Medicare Proposal to Include Personal Exoskeletons in a Medicare Benefit Category to be Paid on a Lump Sum BasisJune 28, 2023 | finance.yahoo.comWe Think ReWalk Robotics (NASDAQ:RWLK) Needs To Drive Business Growth CarefullyJune 7, 2023 | fool.comReWalk Robotics (NASDAQ: RWLK)May 12, 2023 | msn.comReWalk Q1: 40% Revenue Growth, Expanding Margins, Europe Snag & MoreSee More Headlines Receive RWLK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter. Email Address RWLK Company Calendar Last Earnings8/11/2023Today9/22/2023Next Earnings (Estimated)11/06/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RWLK CUSIPN/A CIK1607962 Webwww.rewalk.com Phone(724) 959-0123FaxN/AEmployees56Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.00 High Stock Price Forecast$3.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+305.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,570,000.00 Net Margins-350.43% Pretax Margin-342.10% Return on Equity-27.83% Return on Assets-25.57% Debt Debt-to-Equity RatioN/A Current Ratio11.73 Quick Ratio11.17 Sales & Book Value Annual Sales$5.51 million Price / Sales8.05 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / Book0.67Miscellaneous Outstanding Shares59,940,000Free Float58,678,000Market Cap$44.36 million OptionableNot Optionable Beta2.44 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Lawrence J. Jasinski BS (Age 66)MBA, CEO & Director Comp: $654.03kMr. Michael A. Lawless (Age 55)Chief Financial Officer Comp: $110.24kMs. Miri Pariente (Age 46)VP of Operations, Regulatory & Quality Comp: $335.1kMs. Kathleen O'DonnellVP of Marketing & New Bus. Devel.Mr. Charles RemsbergChief Sales OfficerMs. Judy KulaVP of Customer Service, HR & Bus. AffairsMore ExecutivesKey CompetitorsEargoNASDAQ:EAROceanTech Acquisitions INASDAQ:OTECSientraNASDAQ:SIENCollPlant BiotechnologiesNASDAQ:CLGNMilestone ScientificNYSE:MLSSView All CompetitorsInsiders & InstitutionsGlobal Fund Lp Lind IIBought 19,779 shares on 9/5/2023Total: $13,845.30 ($0.70/share)Global Fund Lp Lind IIBought 11,597 shares on 9/1/2023Total: $8,233.87 ($0.71/share)Joseph E Turk JrBought 2,661 shares on 9/1/2023Total: $1,809.48 ($0.68/share)Jeannine LynchSold 9,529 sharesTotal: $6,575.01 ($0.69/share)Joseph E Turk JrBought 1,616 shares on 8/29/2023Total: $985.76 ($0.61/share)View All Insider TransactionsView All Institutional Transactions RWLK Stock - Frequently Asked Questions Should I buy or sell ReWalk Robotics stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" RWLK shares. View RWLK analyst ratings or view top-rated stocks. What is ReWalk Robotics' stock price forecast for 2023? 1 analysts have issued 1-year target prices for ReWalk Robotics' stock. Their RWLK share price forecasts range from $3.00 to $3.00. On average, they predict the company's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 305.4% from the stock's current price. View analysts price targets for RWLK or view top-rated stocks among Wall Street analysts. How have RWLK shares performed in 2023? ReWalk Robotics' stock was trading at $0.7601 at the beginning of 2023. Since then, RWLK shares have decreased by 2.6% and is now trading at $0.74. View the best growth stocks for 2023 here. When is ReWalk Robotics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023. View our RWLK earnings forecast. How were ReWalk Robotics' earnings last quarter? ReWalk Robotics Ltd. (NASDAQ:RWLK) issued its quarterly earnings results on Friday, August, 11th. The medical device company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.02. The medical device company earned $1.34 million during the quarter, compared to analyst estimates of $1.34 million. ReWalk Robotics had a negative trailing twelve-month return on equity of 27.83% and a negative net margin of 350.43%. What other stocks do shareholders of ReWalk Robotics own? Based on aggregate information from My MarketBeat watchlists, some companies that other ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy Partners (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Roper Technologies (ROP). What is ReWalk Robotics' stock symbol? ReWalk Robotics trades on the NASDAQ under the ticker symbol "RWLK." Who are ReWalk Robotics' major shareholders? ReWalk Robotics' stock is owned by many different institutional and retail investors. Top institutional investors include Osaic Holdings Inc. (1.65%), Osaic Holdings Inc. (1.64%), Renaissance Technologies LLC (0.37%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Global Fund Lp Lind II, Jeannine Lynch, Jeff Dykan, Joseph E Turk Jr, Lawrence J Jasinski and Michael A Lawless. View institutional ownership trends. How do I buy shares of ReWalk Robotics? Shares of RWLK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ReWalk Robotics' stock price today? One share of RWLK stock can currently be purchased for approximately $0.74. How much money does ReWalk Robotics make? ReWalk Robotics (NASDAQ:RWLK) has a market capitalization of $44.36 million and generates $5.51 million in revenue each year. The medical device company earns $-19,570,000.00 in net income (profit) each year or ($0.33) on an earnings per share basis. How can I contact ReWalk Robotics? ReWalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The official website for the company is www.rewalk.com. The medical device company can be reached via phone at (724) 959-0123 or via email at ir@rewalk.com. This page (NASDAQ:RWLK) was last updated on 9/23/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReWalk Robotics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.